Studies using this xenograft model have revealed that P2rx7 mRNA expression is increased during GVHD [247] and that its blockade with BBG can reduce histological and clinical signs of disease and increase human regulatory T cells [129], thus confirming a role for P2X7 in this disease [248]. Here, P2RX7 is linked to graft versus host disease.